Canada’s cancer immunotherapy marke t is expected to grow at a CAGR of 7.1% from a market size of $9 Bn in 2022 to $15.58 Bn in 2030.
Another type of cell therapy is immunotherapy, which involves using immune cells to target and destroy cancer cells. Canada’s cancer immunotherapy marke t is expected to grow at a CAGR of 7.1% from a market size of $9 Bn in 2022 to $15.58 Bn in 2030. Rising cancer prevalence and growing adoption of immunotherapy are the major market drivers.